Interpretation of MRSASelect Screening Agar at 24 Hours of Incubation

被引:18
作者
Carson, Julie [2 ]
Lui, Betty [1 ]
Rosmus, Linda [1 ]
Rennick, Howard [1 ]
Fuller, Jeff [1 ]
机构
[1] Univ Alberta Hosp, Dept Lab Med & Pathol, Div Med Microbiol, Edmonton, AB T6G 2J2, Canada
[2] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; CHROMOGENIC MEDIUM; MRSA-SELECT; CHROMAGAR MRSA; SURVEILLANCE; CULTURES; MEDIA;
D O I
10.1128/JCM.01566-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An incubation time of 24 h at 35 to 38 C is recommended for the optimal performance of MRSASelect (Bio-Rad) chromogenic screening agar. An additional 24 h is required to capture slow-growing methicillin-resistant Staphylococcus aureus (MRSA). However, the normal hours of operation for most laboratories cannot reliably accommodate 24-h interpretation intervals. Daily agar plate interpretations are more likely to occur around 18 h and 42 h of incubation, which may compromise the performance of the chromogenic agar and negatively impact patient infection control efforts. In order to validate the importance of stringent incubation times to plate performance, we evaluated MRSASelect medium at controlled intervals of 24 and 48 h of incubation, using clinical MRSA-screening swabs. A total of 1,071 MRSA-positive and 2,733 MRSA-negative cultures were selected for analysis. Compared to 48-h-incubation results, the sensitivity and specificity of MRSASelect at 24 h were 98.3% and 98.2%, respectively. Only 19 of 1,071 (1.8%) MRSA-positive isolates required 48 h for detection. Holding 24-h negative plates an additional 24 h resulted in the workup of 253 (6.6%) pink, yet non-MRSA, colonies. The 24-h positive and negative predictive values of MRSASelect, assuming MRSA prevalences of 1, 5, and 10%, were 35.5 and 99.98%, 74.2 and 99.9%, and 85.9 and 99.8%, respectively. MRSASelect medium held for 24-h incubation is a highly sensitive and specific MRSA-screening tool. Further incubation prolongs the turnaround time for results and creates a significant amount of unnecessary work in the laboratory.
引用
收藏
页码:566 / 568
页数:3
相关论文
共 13 条
[1]   Evaluation of MRSA Select, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus [J].
Ben Nsira, Sana ;
Dupuis, Michel ;
Leclercq, Roland .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (06) :561-564
[2]  
*CAN NOS INF SURV, 2005, CAN COMMUN DIS REP, V31, P33
[3]   Comparison of four chromogenic media for culture-based screening of meticillin-resistant Staphylococcus aureus [J].
Cherkaoui, Abdessalam ;
Renzi, Gesuele ;
Francois, Patrice ;
Schrenzel, Jacques .
JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (04) :500-503
[4]  
*CLIN LAB STAND I, 2007, M100S17 CLIN LAB S S
[5]   Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures [J].
Jones, EM ;
Bowker, KE ;
Cooke, R ;
Marshall, RJ ;
Reeves, DS ;
MacGowan, AP .
JOURNAL OF HOSPITAL INFECTION, 1997, 35 (01) :59-62
[6]   Evaluation of a new chromogenic medium, MRSA Select, for detection of methicillin-resistant Staphylococcus aureus [J].
Louie, Lisa ;
Soares, Deirdre ;
Meaney, Helen ;
Vearncombe, Mary ;
Simor, Andrew E. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (12) :4561-4563
[7]   SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of staphylococcus aureus and enterococcus [J].
Muto, CA ;
Jernigan, JA ;
Ostrowsky, BE ;
Richet, HM ;
Jarvis, WR ;
Boyce, JM ;
Farr, BM .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (05) :362-386
[8]   Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus [J].
Nahimana, I. ;
Francioli, P. ;
Blanc, D. S. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (12) :1168-1174
[9]   Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus [J].
Perry, JD ;
Davies, A ;
Butterworth, LA ;
Hopley, ALJ ;
Nicholson, A ;
Gould, FK .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) :4519-4523
[10]  
Simor AE, 2001, CAN MED ASSOC J, V165, P21